BackBenitec Biopharma Overview

Benitec Biopharma Net Tangible Assets

Track Benitec Biopharma's net tangible assets ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$183.33M

Peer average

Loading

Benitec Biopharma Net Tangible Assets History

Loading

Benitec Biopharma vs. peers: Net Tangible Assets Comparison

Loading

Benitec Biopharma Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Benitec Biopharma (BNTC) FAQ

Benitec Biopharma posts a net tangible assets of $180M as of March 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Benitec Biopharma's net tangible assets was $0. The latest reading is $180M (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of Benitec Biopharma's financial statement story. At $180M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BNTC's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Benitec Biopharma's other metric pages and overview cover the third.